212 related articles for article (PubMed ID: 30195251)
21. Homology modeling and molecular dynamics simulations of Dengue virus NS2B/NS3 protease: insight into molecular interaction.
Wichapong K; Pianwanit S; Sippl W; Kokpol S
J Mol Recognit; 2010; 23(3):283-300. PubMed ID: 19693793
[TBL] [Abstract][Full Text] [Related]
22. Expression and purification of a two-component flaviviral proteinase resistant to autocleavage at the NS2B-NS3 junction region.
Shiryaev SA; Aleshin AE; Ratnikov BI; Smith JW; Liddington RC; Strongin AY
Protein Expr Purif; 2007 Apr; 52(2):334-9. PubMed ID: 17189703
[TBL] [Abstract][Full Text] [Related]
23. Profiling of flaviviral NS2B-NS3 protease specificity provides a structural basis for the development of selective chemical tools that differentiate Dengue from Zika and West Nile viruses.
Rut W; Groborz K; Zhang L; Modrzycka S; Poreba M; Hilgenfeld R; Drag M
Antiviral Res; 2020 Mar; 175():104731. PubMed ID: 32014497
[TBL] [Abstract][Full Text] [Related]
24. Cleavage of the dengue virus polyprotein at the NS3/NS4A and NS4B/NS5 junctions is mediated by viral protease NS2B-NS3, whereas NS4A/NS4B may be processed by a cellular protease.
Cahour A; Falgout B; Lai CJ
J Virol; 1992 Mar; 66(3):1535-42. PubMed ID: 1531368
[TBL] [Abstract][Full Text] [Related]
25. Specific requirements for elements of the 5' and 3' terminal regions in flavivirus RNA synthesis and viral replication.
Yu L; Nomaguchi M; Padmanabhan R; Markoff L
Virology; 2008 Apr; 374(1):170-85. PubMed ID: 18234265
[TBL] [Abstract][Full Text] [Related]
26. Homology modeling and molecular dynamics study of West Nile virus NS3 protease: a molecular basis for the catalytic activity increased by the NS2B cofactor.
Zhou H; Singh NJ; Kim KS
Proteins; 2006 Nov; 65(3):692-701. PubMed ID: 16972281
[TBL] [Abstract][Full Text] [Related]
27. Steady-state cleavage kinetics for dengue virus type 2 ns2b-ns3(pro) serine protease with synthetic peptides.
Khumthong R; Niyomrattanakit P; Chanprapaph S; Angsuthanasombat C; Panyim S; Katzenmeier G
Protein Pept Lett; 2003 Feb; 10(1):19-26. PubMed ID: 12625822
[TBL] [Abstract][Full Text] [Related]
28. Mutagenesis of the NS3 protease of dengue virus type 2.
Valle RP; Falgout B
J Virol; 1998 Jan; 72(1):624-32. PubMed ID: 9420267
[TBL] [Abstract][Full Text] [Related]
29. The Transactions of NS3 and NS5 in Flaviviral RNA Replication.
Tay MYF; Vasudevan SG
Adv Exp Med Biol; 2018; 1062():147-163. PubMed ID: 29845531
[TBL] [Abstract][Full Text] [Related]
30. Policresulen, a novel NS2B/NS3 protease inhibitor, effectively inhibits the replication of DENV2 virus in BHK-21 cells.
Wu DW; Mao F; Ye Y; Li J; Xu CL; Luo XM; Chen J; Shen X
Acta Pharmacol Sin; 2015 Sep; 36(9):1126-36. PubMed ID: 26279156
[TBL] [Abstract][Full Text] [Related]
31. West Nile Virus (WNV) protease and membrane interactions revealed by NMR spectroscopy.
Gayen S; Chen AS; Huang Q; Kang C
Biochem Biophys Res Commun; 2012 Jul; 423(4):799-804. PubMed ID: 22713461
[TBL] [Abstract][Full Text] [Related]
32. Processing of dengue type 4 and other flavivirus nonstructural proteins.
Lai CJ; Pethel M; Jan LR; Kawano H; Cahour A; Falgout B
Arch Virol Suppl; 1994; 9():359-68. PubMed ID: 8032267
[TBL] [Abstract][Full Text] [Related]
33. Mutagenesis of Dengue Virus Protein NS2A Revealed a Novel Domain Responsible for Virus-Induced Cytopathic Effect and Interactions between NS2A and NS2B Transmembrane Segments.
Wu RH; Tsai MH; Tsai KN; Tian JN; Wu JS; Wu SY; Chern JH; Chen CH; Yueh A
J Virol; 2017 Jun; 91(12):. PubMed ID: 28381578
[TBL] [Abstract][Full Text] [Related]
34. West Nile Virus NS2B/NS3 protease as an antiviral target.
Chappell KJ; Stoermer MJ; Fairlie DP; Young PR
Curr Med Chem; 2008; 15(27):2771-84. PubMed ID: 18991636
[TBL] [Abstract][Full Text] [Related]
35. RNA Helicase A Is an Important Host Factor Involved in Dengue Virus Replication.
Wang Y; Chen X; Xie J; Zhou S; Huang Y; Li YP; Li X; Liu C; He J; Zhang P
J Virol; 2019 Feb; 93(4):. PubMed ID: 30463971
[TBL] [Abstract][Full Text] [Related]
36. Small molecule pan-dengue and West Nile virus NS3 protease inhibitors.
Cregar-Hernandez L; Jiao GS; Johnson AT; Lehrer AT; Wong TA; Margosiak SA
Antivir Chem Chemother; 2011 May; 21(5):209-17. PubMed ID: 21566267
[TBL] [Abstract][Full Text] [Related]
37. Potential Role of Flavivirus NS2B-NS3 Proteases in Viral Pathogenesis and Anti-flavivirus Drug Discovery Employing Animal Cells and Models: A Review.
Wahaab A; Mustafa BE; Hameed M; Stevenson NJ; Anwar MN; Liu K; Wei J; Qiu Y; Ma Z
Viruses; 2021 Dec; 14(1):. PubMed ID: 35062249
[TBL] [Abstract][Full Text] [Related]
38. Structural basis for the activation of flaviviral NS3 proteases from dengue and West Nile virus.
Erbel P; Schiering N; D'Arcy A; Renatus M; Kroemer M; Lim SP; Yin Z; Keller TH; Vasudevan SG; Hommel U
Nat Struct Mol Biol; 2006 Apr; 13(4):372-3. PubMed ID: 16532006
[TBL] [Abstract][Full Text] [Related]
39. Tripeptide inhibitors of dengue and West Nile virus NS2B-NS3 protease.
Schüller A; Yin Z; Brian Chia CS; Doan DN; Kim HK; Shang L; Loh TP; Hill J; Vasudevan SG
Antiviral Res; 2011 Oct; 92(1):96-101. PubMed ID: 21763725
[TBL] [Abstract][Full Text] [Related]
40. Phosphonate inhibitors of West Nile virus NS2B/NS3 protease.
Skoreński M; Milewska A; Pyrć K; Sieńczyk M; Oleksyszyn J
J Enzyme Inhib Med Chem; 2019 Dec; 34(1):8-14. PubMed ID: 30362835
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]